Abstract：Objective: To investigate the factors influencing adverse pregnancy outcomes after laparoscopic surgery in patients with endometriosis and their clinical predictive value. Methods: Clinical data were collected and retrospectively from 124 patients with endometriosis (EMS) who underwent laparoscopic surgery at our hospital from December 2019 to December 2022. The patients were divided into two groups based on their pregnancy outcomes within 2 years after surgery: the good outcome group (77 cases) and the adverse outcome group (47 cases). Univariate analysis was used to compare the age, infertility duration, revised American Fertility Society (r-AFS) staging, Endometriosis Fertility Index (EFI), postoperative medication, postoperative anti-Mullerian hormone (AMH), serum follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), and progesterone (P) levels between the two groups. Multivariate Logistic regression was used to analyze the independent influencing factors of adverse pregnancy outcomes after laparoscopic endometriosis. ROC curve analysis was used to evaluate the predictive value of related indicators, and a nomogram prediction model was constructed and assessed. Results: The age and E2 in the poor outcome group were both greater than those in the good outcome group (P<0.05). The levels of EFI, AMH and P in the poor outcome group were all lower than those in the good outcome group (P<0.05). The results of multivariate analysis showed that EFI score, AMH, E2 and P levels were all independent influencing factors for adverse pregnancy outcomes in patients after laparoscopic surgery (P<0.05). The combination of the four (AUC=0.909) had the highest predictive value for adverse pregnancy outcomes in patients after laparoscopic surgery. The nomogram prediction model constructed based on independent influencing factors has good prediction accuracy and high clinical application value. Conclusion: Low EFI scores, low AMH and P levels, and high E2 levels after surgery can be considered as auxiliary indicators for adverse pregnancy outcomes after laparoscopic surgery in patients with endometriosis, and they are independent influencing factors. The combination of these four factors has the highest predictive value.
师淑静, 张春燕, 裴利花, 高霞, 刘燕, 张丽鹏, 孙文霞. 子宫内膜异位症腹腔镜术后患者不良妊娠结局发生影响因素及其预测价值[J]. 河北医学, 2025, 31(6): 902-907.
SHI Shujing, ZHANG Chunyan, PEI Lihua, et al. Factors Influencing the Occurrence of Adverse Pregnancy Outcomes and Their Predictive Value in Patients after Laparoscopic Surgery for Endometriosis. HeBei Med, 2025, 31(6): 902-907.
[1] 任倩慧,王国云.子宫内膜异位症生育指数评分及其临床意义[J].中国实用妇科与产科杂志,2024,40(5):500-503. [2] 赵颖,张杰,金秋利.子宫内膜异位症生育指数联合血清AMH对子宫内膜异位症患者自然妊娠结局的预测价值[J].中国实用医药,2024,19(11):90-93. [3] 中国医师协会妇产科医师分会,中华医学会妇产科学分会子宫内膜异位症协作组.子宫内膜异位症诊治指南(第三版)[J].中华妇产科杂志,2021,56(12):13. [4] Liu N,Bao R H,Chang Y J,et al.Adverse pregnancy outcomes and multiple cancers risk in both mother and offspring:an umbrella review of systematic reviews with meta-analyses of observational studies[J].BMC Medicine,2024,22(1):454. [5] 王刚,陈捷,邓凯贤,等.子宫内膜异位症腔镜诊治术后长期管理专家建议[J].中国计划生育和妇产科,2022,14(7):3-6,30. [6] 胡婷婷,马天宇,倪娟.子宫内膜异位囊肿患者血清抗苗勒氏管激素、卵泡刺激素、黄体生成素和雌二醇表达水平及对预后的预测价值[J].中国卫生检验杂志,2023,33(1):4-7,23. [7] Yin H,Chen J,Chen Q,et al.Assessment of ovarian reserve function in patients with adenomyosis and ovarian endometriosis by three-dimensional transvaginal ultrasound and Anti-Mullerian hormone[J].Scientific Reports,2024,14(1):30799. [8] 冯力元,邓姗.术前抗苗勒管激素水平不能准确预测卵巢子宫内膜异位症囊肿不孕患者术后的生育结局[J].生殖医学杂志,2023,32(7):991-996. [9] Marquardt R M,Kim T H,Shin J H,et al.Progesterone and estrogen signaling in the endometrium:what goes wrong in endometriosis[J].International Journal of Molecular Sciences,2019,20(15):3822. [10] 张琦,周锋,李岚,等.子宫内膜异位症患者腹腔镜手术后首次IVF-ET的治疗结局分析[J].中华妇产科杂志,2023,58(2):91-97. [11] 刘海燕.血清雌孕激素联合子宫内膜异位症生育指数预测子宫内膜异位症不孕症患者腹腔镜术后自然妊娠成功率的价值[J].中国妇幼保健,2021,36(10):2325-2327. [12] 李红.生育力指数及T淋巴细胞亚群对子宫内膜异位症合并不孕症腹腔镜术后患者预后的影响[J].中国生育健康杂志,2021,32(3):238-242.
2025, Vol. 31 
冀公网安备13080202000786号